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Abstract
Background: The establishment and maintenance of polarity is vital for embryonic development and loss of
polarity is a frequent characteristic of epithelial cancers, however the underlying molecular mechanisms remain
unclear. Here, we identify a novel role for the polarity protein Scrib as a mediator of epidermal permeability barrier
acquisition, skeletal morphogenesis, and as a potent tumor suppressor in cutaneous carcinogenesis.
Methods: To explore the role of Scrib during epidermal development, we compared the permeability of toluidine
blue dye in wild-type, Scrib heterozygous and Scrib KO embryonic epidermis at E16.5, E17.5 and E18.5. Mouse
embryos were stained with alcian blue and alizarin red for skeletal analysis. To establish whether Scrib plays a tumor
suppressive role during skin tumorigenesis and/or progression, we evaluated an autochthonous mouse model of
skin carcinogenesis in the context of Scrib loss. We utilised Cre-LoxP technology to conditionally deplete Scrib in
adult epidermis, since Scrib KO embryos are neonatal lethal.
Results: We establish that Scrib perturbs keratinocyte maturation during embryonic development, causing impaired
epidermal barrier formation, and that Scrib is required for skeletal morphogenesis in mice. Analysis of conditional
transgenic mice deficient for Scrib specifically within the epidermis revealed no skin pathologies, indicating that
Scrib is dispensable for normal adult epidermal homeostasis. Nevertheless, bi-allelic loss of Scrib significantly
enhanced tumor multiplicity and progression in an autochthonous model of epidermal carcinogenesis in vivo,
demonstrating Scrib is an epidermal tumor suppressor. Mechanistically, we show that apoptosis is the critical
effector of Scrib tumor suppressor activity during skin carcinogenesis and provide new insight into the function of
polarity proteins during DNA damage repair.
Conclusions: For the first time, we provide genetic evidence of a unique link between skin carcinogenesis and loss
of the epithelial polarity regulator Scrib, emphasizing that Scrib exerts a wide-spread tumor suppressive function in
epithelia.
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Introduction
SCRIB is a large scaffold protein containing 16 leucine-
rich repeats (LRRs) and 4 PDZ (PSD95-DLG1-ZO1)
protein-interacting domains that interact with Discs
large 1–4 (DLG1-4) and Lethal giant larvae (LGL1/2) to
form the Scribble complex. The Scribble complex re-
sides along the basolateral membrane of epithelial cells
and is concentrated at cell-cell junctions [1–3]. In con-
cert with the polarity program, the Scribble complex en-
gages multiple signal transduction cascades to establish
apical-basal and planar cell polarity to regulate key cellular
processes including proliferation, apoptosis and differenti-
ation [1–4]. Consequently, loss of epithelial organisation/
polarization causes aberrant embryonic morphogenesis
[5–11], and is a common feature during epithelial cancer
formation and progression [1–4, 7].
Scrib is an essential gene in flies and mammals; scrib
mutant Drosophila larvae fail to pupate owing to lethal
overgrowth [5] and Scrib null mice are neonatal lethal
owing to severe neural tube and abdominal wall closure
defects [7, 8, 10]. During embryonic development, Scrib
is also required for lung morphogenesis [9] and cochlear
sterociliary bundle organisation [12], underlining the
possibility that Scrib universally mediates epithelial
morphogenesis.
Establishment of a functional epidermal permeability
barrier (EPB) is essential for post-natal survival of all ter-
restrial life, preventing dehydration and protecting
against physical, chemical and mechanical damage [13–
15]. EPB formation occurs during late gestation within
the outer layer of the epidermis termed the stratum cor-
neum (SC), which comprises corneocytes (terminally dif-
ferentiated keratinocytes) surrounded by extracellular
lipid lamellae [13–15]. The complex assembly of the
EPB involves the provision of lipids and proteins from
lamellar granules in the stratum granulosum (SG) to the
SC, keratins, cross-linking of envelope proteins (e.g. lori-
crin and involucrin), and membrane-anchoring proteins
(e.g. envoplakin) [13–16]. In addition, tight junctions are
also necessary within the SG to mediate paracellular
transport and apical-basal polarity for EPB function [17].
Developing a comprehensive molecular understanding
of EPB acquisition is paramount for improving our man-
agement of common skin disorders associated with an
EPB defect, such as psoriasis and dermatitis. Emerging
evidence in the literature suggests that aberrant cell po-
larity may hinder multiple processes required for EPB
acquisition. For example, atypical Protein Kinase C
(aPKC), which forms the Par3 apical polarity complex
with the PAR (partitioning-defective) proteins Par3 and
Par6, has been shown to be required for tight junction
formation and barrier function in vitro [18]. In addition,
the planar cell polarity protein Grainyhead-like-3 (Grhl3)
and E-cadherin have been previously shown to regulate
EPB acquisition by mediating SC formation, cell adhe-
sion and/or extracellular lipid composition in the SG in
vivo [19–22]. Taken together, these data indicate that
an intact polarity network is necessary for EPB assem-
bly, however the true extent of the polarity network’s
involvement during EPB acquisition and the molecular
mechanisms involved remain elusive.
Mature mammalian skin is comprised of multiple
keratinised and stratified layers of polarised squamous
epithelial cells and constantly undergoes a high rate of
self-renewal. Basal keratinocytes continually proliferate
to replace suprabasal keratinocytes that terminally dif-
ferentiate as they migrate towards the surface, and are
finally sloughed off from the dead/flattened cornified
layer [23]. Events that cause an imbalance between
keratinocyte self-renewal, differentiation and matur-
ation processes result in cutaneous disorders including
eczema, psoriasis [24] and skin cancer [20, 25]. Basal
cell carcinoma (BCC) and squamous cell carcinoma
(SCC) comprise the majority of non-melanoma skin
malignancies, and the latter is a major cause of death
worldwide owing to insufficient treatment of metastatic
disease [26]. Accordingly, there is an urgent need to
improve our molecular understanding of cutaneous
skin cancers to identify new routes for therapeutic
intervention and novel biomarkers.
In keeping with the concept that oncogenesis involves
abnormal signalling through pathways that regulate em-
bryonic development, Scrib has been shown to play a
tumor suppressive function in multiple epithelial tissues
[7, 27–30] and is frequently deregulated and mislocalised
in human epithelial cancers [7, 27, 31, 32]. Furthermore,
shRNA-mediated SCRIB knockdown in a non-tumorigenic
human keratinocyte cell line (HaCaT) is reported to be
sufficient to increase cell growth, reduce cell-cell con-
tacts and increase invasion in vitro [33].
Collectively, this evidence suggests a potential role
for Scrib during embryonic development and cancer
formation and progression in skin. To directly test
this hypothesis in vivo, we have characterised the epider-
mal phenotype of Scrib-deficient embryos and adult mice
using a conditional transgenic approach. We show that bi-
allelic loss of Scrib causes a transient delay in the acquisi-
tion of the skin permeability barrier at E17.5, which was
associated with impaired keratinocyte maturation. Ana-
lysis of adult epidermis identified that Scrib is not required
for normal murine epidermal homeostasis, but can fa-
cilitate tumor initiation and progression in the two-step
7,12-Dimethylbenz(a)anthracene/12-O-Tetradecanoylphor-
bol-13-acetate (DMBA/TPA) skin carcinogenesis model by
reducing apoptosis. Concurrently, these data are the
first to establish Scrib as a mediator of EPB formation
and a potent tumor suppressor during epidermal car-
cinogenesis and progression.
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Results
Scribble loss impairs embryonic skin permeability barrier
function
To determine the role of Scrib during epidermal embry-
onic development, we initially examined the flank epi-
dermis from viable wild-type (Wt) and Scrib+/− (Het)
embryos compared to neonatal lethal Scrib-/- knockout
(KO) embryos at E16.5, E17.5 and E18.5 (n = 8–29 per
genotype and time point). Germline Cre-deleter driven
recombination results in the systemic excision of a LoxP
site flanking exons 4–13 of the Scrib gene, resulting in a
frame-shift mutation and premature truncation of the
protein (Fig. 1a). The remaining N-terminal product (ap-
proximately 100aa) has no known function. Quantitative
real-time PCR (qRT-PCR) analysis confirmed a signifi-
cant reduction in Scrib mRNA transcript expression
levels in Het and KO embryonic flank skin compared to
Wt littermates at E16.5 (Fig. 1b). Immunofluorescence
(IF) to detect Scrib protein revealed uniform membran-
ous staining in Wt and Het embryonic epidermal cells
that is absent in KO littermates at E18.5 (Fig. 1c).
To establish whether Scrib is required for EPB acquisi-
tion, we assessed the penetration of toluidine blue dye
in Scrib-deficient embryonic epidermis at several stages of
development (Fig. 1d, n = 4–10 per genotype/time point).
At E16.5, Wt and Scrib-deficient embryos displayed global
dye penetration, consistent with previous work demon-
strating that permeability barrier formation begins at this
time point, but is not yet fully established [34]. By E17.5,
Wt and Het embryos are resistant to toluidine blue perme-
ation, reflecting SC formation and a functional EPB. In
contrast, Scrib KO embryos displayed intense blue staining
at E17.5, suggesting impaired barrier formation. Neverthe-
less, by E18.5 Scrib KO embryos did not allow dye pene-
tration (except in exposed neural tube and eye) (Fig. 1d).
Taken together, our findings indicate that Scrib deletion
causes a transient delay in epidermal barrier acquisition at
E17.5. Consistent with this, histological analysis revealed
that Scrib KO flank skin was markedly thinner (Fig. 1e),
and quantitation revealed a significant reduction in epi-
dermal thickness at E16.5 and E17.5 compared to Wt and
Het embryos that was recovered at E18.5 (Fig. 1f).
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Fig. 1 Scrib KO embryos display a transient delay in epidermal permeability barrier acquisition. a Schematic representation of floxed targeting
construct and mutated Scrib alleles. LoxP sites are represented by orange triangles. Cre-mediated recombination results in excision of exons 4–13,
which introduces a frame-shift mutation that truncates the protein. b qRT-PCR to detect Scrib mRNA in embryonic skin at E16.5 (n = 3). Error
bars: SD, *p < 0.0001 (unpaired t-test). c IF to detect Scrib (green) and DAPI (blue) in embryonic flank epidermis at E18.5 (n = 3 per genotype, scale
bar = 50 μm. Inserts 1–3 scale bar = 10 μm). Scrib staining was detected along the membrane cortex of epidermal epithelial cells in Wt and Het
embryonic epidermis and was absent in Scrib KO embryos. All genotypes displayed non-specific epidermal surface staining. d Representative
images of toluidine blue skin permeability barrier assay (scale bar: 1 cm, n = 4–10 per genotype/time point). e H&E images of Wt, Het and KO
epidermis at E16.5, E17.5 and E18.5, dashed line represents basement membrane, arrows indicate width of epidermis measured (n = 8–29 per
genotype/time point, scale bar: 50 μm). f Quantitation of embryonic epidermal thickness. Error bars: SD, *p≤ 0.0227 (2-way ANOVA with Tukey
correction), n = 3 per genotype at each time point
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To investigate whether the delay in skin barrier forma-
tion we observe in Scrib KO embryos was simply due to
a generalised delay in developmental timing, we analysed
formation of the forelimb. Limb morphogenesis is highly
stereotyped and as such, is commonly used as an indica-
tor of developmental stage. Staining of E17.5 forelimbs
with alcian blue and alizarin red, to detect cartilage and
bone respectively, revealed no obvious difference in bone
size, morphology or pattern of ossification in KO fore-
limbs compared to Wt or Het littermates (Fig. 2a; n = 3–6).
At early stages of forelimb development, characteristic digit
morphology and the dynamic pattern of interdigital apop-
tosis were unchanged in E13.5 KO embryos when com-
pared to Wt or Het littermate embryos (Fig. 2b; n = 3).
Together, these data indicate that a global delay in develop-
mental timing is not responsible for the observed defects
we see in skin barrier formation, and suggest that Scrib
plays a specific role in regulating epidermal development.
Nevertheless, although these data strongly suggest that the
transient delay in EPB formation observed in Scrib KO
embryos is most likely not a consequence of systemic ab-
normal development, we cannot completely exclude this
possibility.
Interestingly, staining for bone and cartilage in Scrib
KO embryos at E17.5 revealed widespread dysregulation
of skeletal morphogenesis outside of the limb that to our
knowledge has not been reported previously (Fig. 2c;
n = 3–6). Scrib KO embryos were not only smaller, but
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Fig. 2 Scrib KO embryos display normal developmental timing, proliferation and tight junction distribution. a Analysis of forelimb skeletal
morphology following alcian blue and alizarin red staining at E17.5. No obvious developmental delay was observed in Scrib KO forelimbs when
compared with Wt or Het littermates (scale bar = 2 mm, n = 3–6). b At E13.5, the characteristic pattern of interdigital apoptosis as revealed by
Lysotracker incorporation (white arrowheads) indicates no obvious developmental delay in Scrib KO embryos when compared with Wt or Het
littermates (scale bar = 1 mm, n = 3). c Whole E17.5 embryo skeletal analysis (scale bar: 5 mm, n = 3–6) reveals extensive dysmorphology in Scrib
KO embryos, including (d) loss of dorsal cranial bones such that the basi-occipital bone (asterix) visible in dorsal view, (e) vertebral fusion (e, red
arrowhead), hemivertebra (e, yellow arrowhead) and (f) distal rib fusion . Scale bar in d-f = 1 mm, n = 3. g IHC to detect PCNA in Scrib Wt, Het and
KO embryonic epidermis at E16.5 (scale bar: 50 μm, n = 3, dashed line represents basement membrane). h IF images to detect ZO-1 (green) in
Scrib Wt, Het and KO embryonic epidermis at E17.5 (scale bar = 50 μm, DAPI = blue, n = 3, dashed line represents basement membrane). i Tight
junction ultrastructure analysis within the granular layer of Scrib Wt, Het and KO embryonic epidermis at E17.5 at 8,000x, 33,000x and 46,000x
magnification (scale bar = 0.5 μm, TJ = tight junction and D = desmosome, n = 3–6). Scrib Wt, Het and KO embryos displayed a similar frequency
of TJs with normal morphology within the SG
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displayed loss of dorsal cranial bones, hemivertebra and
widespread proximal and distal rib fusions (Fig. 2d-f) re-
sembling Chuzhoi mutant mouse embryos that harbour a
mutation in the polarity gene Ptk7 [35] and Dvl2−/− mouse
embryos [36], further illustrating the importance of this
network during development.
Although we observe multiple developmental and
skeletal abnormalities in Scrib KO embryos, our analysis
of interdigital apoptosis and limb morphogenesis
strongly indicates that developmental timing is not
broadly disrupted. Thus, we reasoned that the transient
delay in epidermal barrier acquisition might reflect im-
paired proliferation, Tight Junction (TJ) formation and/
or keratinocyte maturation. To test this, we first analysed
proliferation by performing immunohistochemistry (IHC)
to detect the proliferation marker PCNA at E16.5, E17.5
and E18.5 (Fig. 2 g and data not shown, n = 3 per geno-
type/time-point). Remarkably, Wt and Scrib-deficient
embryonic epidermis displayed a similar number of
PCNA-positive cells, indicating that Scrib loss does not
cause a transient delay in EPB acquisition by reducing
proliferation.
IF to detect the TJ protein ZO-1 revealed that Scrib
Wt, Het and KO embryonic epidermis display compar-
able, uniform membranous ZO-1 staining (Fig. 2 h, n = 3),
indicating that impaired TJ formation is not responsible
for the observed delay in EPB formation in Scrib KO
embryos. In support, ultrastructure analysis of Scrib KO
embryonic flank epidermis revealed normal TJ morph-
ology (e.g. kissing points) that were comparable to Wt
and Het littermates at E17.5 (Fig. 2i, n = 3–6). Further-
more, we did not observe any changes in the distribu-
tion of the apical-basal polarity protein Dlg or the
Adheren’s Junction (AJ) component and polarity pro-
tein E-cadherin (Additional file 1: Figure S1, n = 3).
Collectively, these data suggest that delayed EPB forma-
tion in Scrib KO embryos is not the result of aberrant
polarity or cell-cell adhesions.
To assess whether Scrib loss disrupts keratinocyte
maturation, we measured the thickness of both the SC
and the SG in Scrib Wt, Het and KO epidermis at E16.5,
E17.5 and E18.5. We show that Scrib KO embryos dis-
play a significant reduction in SC and SG thickness at
E17.5 compared to Wt and Het littermates (Fig. 3a-c,
n = 3). Since SG and SC thickness is restored and par-
tially recovered respectively in Scrib KO epidermis at
E18.5, these data suggest that Scrib loss perturbs kera-
tinocyte maturation to delay EPB formation. In sup-
port, co-staining for the spinous layer cytoskeletal
protein cytokeratin 10 (K10) and the SG component
loricrin, revealed that at E16.5 and E17.5, Scrib KO
epidermis displays a diminished SC and limited SG
formation compared to Wt and Het littermates, which
recovered at E18.5 (Fig. 3d, n = 3).
Scrib is not essential for the maintenance of epidermal
tissue homeostasis
Given that Scrib facilitates EPB acquisition during devel-
opment, we next analysed whether Scrib functions to
maintain epidermal homeostasis in adult mice. As Scrib
KO mice are neonatal lethal, we crossed K14Cre(Δneo)
mice [37] with Scrib floxed mice [7] to specifically delete
Scrib in the entire epidermis after birth. Cohorts of
K14Cre+/−;Scrib+/+, K14Cre+/−;Scrib+/fl or K14Cre+/−;Scribfl/fl
mice (hereafter denoted Scrib+/+, Scrib+/fl, Scribfl/fl re-
spectively) were generated and aged to 100 days (n =
10). PCR analysis of genomic DNA isolated from dorsal
skin confirmed recombination of the Scrib+/fl and
Scribfl/fl alleles in the epidermis, while only the Wt al-
lele was present in control animals (Fig. 4a). QRT-PCR
to detect Scrib confirmed that mRNA transcript levels
were significantly decreased by 56.3 % (±1.92 SD) and
89.0 % (±1.84 SD) in Scrib+/fl and Scribfl/fl mice respect-
ively (Fig. 4b). Histological analysis of adult epidermis
at 100 days revealed no obvious phenotypic difference in
Scrib+/+, Scrib+/fl, Scribfl/fl epidermis, despite the absence
of Scrib protein in Scribfl/fl epidermal cells, determined
by IF staining (Fig. 4c). Scrib+/+ and Scrib+/fl mice
showed strong, continuous Scrib staining within the
membrane cortex of epidermal cells. Together, these
findings indicate that Scrib is dispensable for the main-
tenance of adult epidermal tissue homeostasis.
To confirm Scrib is not required for normal adult skin
homeostasis, we first performed IHC for PCNA, to visualise
proliferating cells, and Cleaved Caspase-3 (CC3) to visualise
apoptotic cells. Enumeration of these IHC identified that
there was no significant difference in the number of prolifer-
ating or apoptotic cells in the epidermis of Scrib+/+, Scrib+/fl
and Scribfl/fl mice (Fig. 4c-e) at 100 days (n= 3). In support,
qRT-PCR to detect mRNA expression of the stem cell gene
Lgr5 revealed no significant difference in transcript levels in
Scrib+/+, Scrib+/fl and Scribfl/fl epidermis (Additional file 2:
Figure S2A, n = 3). Cytokeratin 6 (K6) is detected in the
interfollicular epidermis only during hyperproliferative con-
ditions, including psoriasis [38] and wound healing [39],
and thus can be used as a surrogate marker of aberrant
homeostasis in the epidermis. IHC to detect cytokeratin 6
(K6) confirmed that K6 was restricted to the hair follicles in
Scrib+/+ and Scrib-deficient epidermis (Additional file 2:
Figure S2B, n = 3), indicative of normal homeostatic condi-
tions [38]. Finally, we investigated differentiation in the epi-
dermis by performing co-IF staining for basal (K5) and
suprabasal (K10) differentiation markers, which revealed no
difference between Scrib+/+, Scrib+/fl and Scribfl/fl adult epi-
dermis (Additional file 2: Figure S2C, n = 3). Importantly,
skin pathologies were not observed in aged Scrib+/+,
Scrib+/fl and Scribfl/fl mice (400 d, n = 10, data not
shown). Collectively, these data indicate that Scrib is
not essential for murine adult epidermal homeostasis.
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Fig. 4 Scrib is dispensable for the maintenance of normal adult epidermal homeostasis. a PCR analysis of genomic DNA to detect Wt (290 bp),
floxed (390 bp) and recombined (550 bp) Scrib alleles in Scrib+/+, Scrib+/fl and Scribfl/fl adult dorsal epidermis (n = 3). b qRT-PCR for Scrib mRNA
confirmed a significant reduction in Scrib+/fl and Scribfl/fl adult dorsal epidermis compared to Scrib+/+ controls (*p≤ 0.0001, unpaired t-test, n = 3).
c Representative H&E (n = 10), Scrib IF (Scrib = green, DAPI = blue), PCNA IHC and CC3 IHC images of Scrib+/+, Scrib+/fl and Scribfl/fl adult dorsal
epidermis (n = 3). Scale bar = 50 μm (insert 1–3: scale bar = 10 μm). Arrow represents positive CC3 staining. Quantitation of nuclear PCNA (d) and
CC3 (e) positive cells in adult dorsal epidermis shows no significant difference in Scrib-deficient epidermis compared to Scrib+/+ controls (p ≥
0.6188, unpaired t-test, n = 3). Adult mice were 100 day old. Error bars = SD
(See figure on previous page.)
Fig. 3 Scrib KO embryos display a transient delay in keratinocyte maturation. a Toluidine blue stained ultramicrotome sections of Scrib Wt, Het
and KO embryonic flank epidermis at E16.5, E17.5 and E18.5 indicating stratum corneum (SC, orange) and stratum granulosum (SG, yellow)
thickness (scale bar = 50 μm, dashed line represents basement membrane, n = 3). Quantitation of stratum corneum (b) and stratum granulosum
(c) thickness in Scrib Wt, Het and KO embryonic flank epidermis at E16.5, E17.5 and E18.5 (*P ≤ 0.0066, two-way ANOVA with Tukey correction,
error bars = SD, n = 3). d IF to detect K10 (green), loricrin (red) and DAPI (blue) in Scrib Wt, Het and KO embryonic flank epidermis at E16.5, E17.5
and E18.5 (scale bar = 100 μm, dashed line represents basement membrane, n = 3)
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Scrib suppresses tumor formation during DMBA/TPA-induced
skin carcinogenesis
We have previously shown that conditional homozygous
deletion of Scrib mediated by Probasin- and MMTV-
driven Cre-recombinase expression causes low-grade
prostate intraepithelial neoplasia and mammary gland
dysplasia respectively in mice, establishing that Scrib is a
mammalian tumor suppressor gene [7, 30]. To examine
the role of Scrib during epidermal tumor initiation/pro-
gression, we used the well-characterised DMBA/TPA
two-step chemical skin carcinogenesis model [40, 41].
DMBA invariably induces HRas activating mutations,
while TPA promotes tumor growth by deregulating sev-
eral signaling networks, including the PKC-Ras/MAPK
cascade that mediates proliferation, differentiation and
inflammation [42–44].
Cohorts of Scrib+/+, Scrib+/fl and Scribfl/fl mice were
generated (n = 12–16; mixed gender) and underwent
long-term DMBA/TPA treatment at 8 weeks of age
(Fig. 5a). Weekly examination of dorsal epidermis
revealed that papillomagenesis initiated 7 weeks post-
DMBA in Scrib+/+, Scrib+/fl and Scribfl/fl mice (Fig. 5b
and c), indicating that Scrib loss does not disturb the
latency of DMBA/TPA-induced epidermal lesions.
Notably, the entire Scribfl/fl cohort had developed epider-
mal lesions at 14 weeks post-DMBA, while 43.7 %
and 33.3 % of Scrib+/+ and Scrib+/fl cohorts respectively
were tumor free (Fig. 5b). Indeed, 30.0 % of Scrib+/+ and
13.3 % of Scrib+/fl mice remained tumor-free during the
course of the experiment (Fig. 5b), however overall sur-
vival was not significantly different between genotypes
(Additional file 3: Figure S3A). qRT-PCR of RNA iso-
lated from epidermal lesions and IF to detect Scrib con-
firmed Scrib mRNA is significantly reduced in Scrib+/fl
and Scribfl/fl lesions compared to Scrib+/+ controls, and
that Scrib protein is uniformly distributed at the mem-
brane cortex in Scrib+/+ and Scrib+/fl DMBA/TPA
lesions, but negligible in Scribfl/fl mice (Additional file 3:
Figure S3B and C; n = 3). These data demonstrate that
Scrib confers a tumor suppressive role during DMBA/
TPA-induced skin carcinogenesis.
Quantitation of lesion multiplicity revealed that the in-
cidence of DMBA/TPA-induced lesions is increased in
Scribfl/fl mice compared to Scrib+/+ and Scrib+/fl mice
A
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Fig. 5 Scrib deficiency facilitates DMBA/TPA-induced epidermal lesion growth. a Diagram illustrating long-term two-step DMBA/TPA carcinogenesis
approach initiated at 8 weeks of age. b Lesion-free percentage, (c) representative photographs of dorsal skin at 7, 14 and 26 weeks post-DMBA (scale
bar: 1 cm, arrows indicate lesion onset), (d) lesion multiplicity plot (error bars = SEM) and (e) histogram to illustrate volume distribution of DMBA/
TPA-induced epidermal lesions in Scrib+/+, Scrib+/fl and Scribfl/fl mice (n = 12–16)
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(Fig. 5d). In addition, half of the Scribfl/fl cohort (6/12)
developed lesions that reached our ethical size limit and
were sacrificed prior to 26 weeks post-DMBA, compared
to only 20 % (3/15) and 25 % (4/16) of the Scrib+/+ and
Scrib+/fl cohorts respectively (Additional file 3: Figure
S3A). Scribfl/fl mice also developed larger DMBA/TPA-in-
duced lesions compared to Scrib+/+ and Scrib+/fl mice at
comparable time-points (Fig. 5e; 7, 10, 12 and 14-weeks
post DMBA treatment shown). Together, these data indi-
cate that bi-allelic loss of Scrib sensitises the epidermis to
papillomagenesis and facilitates their growth.
Scrib loss facilitates invasive SCC progression in DMBA/
TPA-induced skin carcinogenesis
Histological analysis of Scrib+/+, Scrib+/fl and Scribfl/fl
mice at sacrifice determined that long-term DMBA/TPA
treatment causes epidermal hyperplasia, benign papillo-
mas and invasive SCC in Scrib+/+, Scrib+/fl and Scribfl/fl
mice (Fig. 6a). While only a single SCC was observed in
the Scrib+/+ cohort (3.8 % incidence), Scrib+/fl and
Scribfl/fl mice displayed an increased frequency of benign
papilloma progression to invasive SCC (14 % and 25 %
incidence respectively) (Fig. 6b). Thus, epidermal tumor
progression correlates directly with reduced Scrib
expression.
Next, we assessed the proliferation status of volume-
matched (40 – 80 mm3) early benign papillomas from
all 3 genotypes, to ascertain whether Scrib loss can ac-
celerate DMBA/TPA-induced papilloma growth. IHC to
detect BrdU incorporation revealed that bi-allelic Scrib
loss causes a small, yet significant increase in the num-
ber of mitotic cells (37.3 % ± 1.754 SD) compared to
Scrib+/fl (32.3 % ± 1.742 SD) or Scrib+/+ (33.1 % ± 0.991
SD) papillomas (Fig. 6c and d). Thus, elevated prolifera-
tion contributes to the observed increased in DMBA/
TPA epidermal tumor volume in Scribfl/fl mice.
Given that DMBA initiation invariably causes activat-
ing Ras mutations in murine epidermis [45], these find-
ings support previous work demonstrating that Scrib
loss cooperates with Ras oncogenic activation to pro-
mote progression and/or invasion [7, 29, 30, 46]. How-
ever, we did not observe any significant changes in the
number of p-ERK positive nuclei in DMBA/TPA-in-
duced size-matched benign papillomas from Scrib+/+,
Scrib+/fl and Scribfl/fl (Additional file 3: Figure S3D and E),
suggesting that the increased tumour phenotype observed
upon deletion of Scrib is unlikely to reflect changes in Ras/
MAPK signalling.
Of note, we did not detect any alteration in the distri-
bution of the tight-junction protein ZO-1, or the AJ
component E-cadherin (Additional file 3: Figure S3F,
n = 3), that has been previously shown to co-localise
with Scrib to regulate E-cadherin-mediated cell-cell
adhesion [47]. These data suggest that Scrib does
not alter cell-cell adhesion to facilitate DMBA/TPA
progression.
Papillomas developed significantly faster in Scribfl/fl
mice suggesting that loss of Scrib may provide a tumor
promoting environment in the skin. To investigate if
Scrib loss promotes the survival of transformed cells in
the DMBA/TPA model, we performed IHC to detect
CC3 in volume-matched early benign papillomas ex-
pressing either Scrib+/+, Scrib+/fl or Scribfl/fl alleles
(Fig. 6c). Immunostaining quantitation revealed that the
number of CC3 positive cells in Scribfl/fl papillomas was
significantly reduced compared to Scrib+/+ or Scrib+/fl
papillomas (Fig. 6e). In support, we show that the number
of cells positive for the histone variant H2AX phosphory-
lated at Ser139 (termed γH2AX), previously shown to be
associated with ATM- and JNK-dependent apoptosis [48,
49], directly correlates with the number of CC3-
positive apoptotic cells (Fig. 6c and f ). Taken together,
our findings indicate that Scrib deletion promotes
DMBA/TPA-induced epidermal lesion growth by en-
hancing proliferation and survival of transformed cells.
As Scribfl/fl mice were more predisposed to develop
DMBA/TPA-induced lesions (Fig. 5b-e), this suggests
that Scrib loss may sensitize the epidermis to cutaneous
carcinogenesis. To investigate this, we performed a
short-term DMBA/TPA study to analyse Scrib-deficient
epidermis prior to papillomagenesis. To this end, Wt,
Scrib+/fl and Scribfl/fl mice received a single topical appli-
cation of DMBA, followed by 4 weeks of TPA treatment
(Fig. 7a; n = 4–7; mixed gender). Histological analysis of
short-term cohorts revealed comparable hyperplastic
epidermis associated with epidermal thickening was
present in all 3 genotypes (Fig. 7b). We next analysed
proliferation rates by quantitating IHC to detect BrdU-
positive cells. Surprisingly, Scrib loss does not affect
proliferation in DMBA/TPA-induced pre-neoplastic
epidermis (Fig. 7b and c). In corroboration, neither
DMBA nor TPA treatment alone was sufficient to in-
duce a proliferative advantage in Scrib deficient skin
(Fig. 7c and Additional file 4: Figure S4A). Taken to-
gether, our findings suggest that although Scrib can
suppress proliferation to inhibit the growth of estab-
lished DMBA/TPA-driven papillomas, Scrib does not
affect DMBA/TPA-induced proliferation during the
pre-neoplastic state.
The dermal infiltration of immune cells in response to
TPA has previously been shown to augment proliferation
and promote skin carcinogenesis (reviewed in [50]). Our
analysis of mast cells (toluidine blue staining) and macro-
phages (IHC to detect F4/80) in Scrib+/+ and Scrib-defi-
cient epidermis that has undergone short-term treatment
with either acetone, DMBA, TPA or DMBA/TPA revealed
no difference in the frequency of these immune cell types
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(Additional file 4: Figure S4B and C). These data indicate
that Scrib deletion is not likely to facilitate tumour initi-
ation/growth by mediating inflammatory responses.
Since we observed no changes in proliferation in pre-
neoplastic Scrib-deficient epidermis, we next investigated
the apoptotic index in these mice. Importantly, acetone
controls confirmed that Scrib loss is not sufficient to alter
CC3-mediated keratinocyte apoptosis. However, compared
to Scrib+/+ and Scrib+/fl mice, the number of CC3-positive
cells detected by IHC was significantly decreased in
Scribfl/fl epidermis treated with either DMBA, TPA or
DMBA/TPA for 4 weeks (Fig. 7b, d and Additional file
5: Figure S5A). Likewise, DMBA treatment (+/− TPA) sig-
nificantly reduced the number of γH2AX-positive cells
in Scribfl/fl epidermis (Fig. 7b, e and Additional file 5:
Figure S5B), however the number of p53 and p21 positive
nuclei remained unchanged (Additional file 5: Figure S5C-
E, and data not shown). Thus, these data suggest that
Scrib loss impairs the DMBA/TPA-induced apoptotic re-
sponse via a p53-independent mechanism, presenting a
direct mechanism whereby loss of Scrib causes a pre-
neoplastic setting in the epidermis.
Discussion
An impaired epidermal barrier can lead to skin diseases
such as psoriasis and eczema, as well as mortality in
pre-mature babies. Accordingly, furthering our under-
standing of the molecular and biochemical events under-
pinning EPB assembly is paramount to improving our
management of skin disorders and pre-mature births.
Our data are the first to demonstrate that the polarity
regulator Scrib plays a role in the acquisition of the
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IHC in Scrib+/+, Scrib+/fl and Scribfl/fl epidermis (per 40x magnification field) that have undergone short-term treatment with either acetone,
DMBA, TPA or DMBA/TPA (*p ≤ 0.0402, two-way ANOVA with Tukey correction, error bars = SD, n = 3). Acetone topical applications served
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permeability barrier during mouse embryonic develop-
ment, but is not essential for EPB formation. Our assess-
ment of developmental timing and epidermal barrier
components in Scrib KO embryos indicates that the
transient delay in epidermal barrier acquisition reflects a
delay in the maturation of keratinocytes. In support,
transgenic mice deficient for the cornified envelope pro-
teins loricrin or envoplakin are also predisposed to delayed
barrier formation [51, 52]. Thus, we conclude that al-
though Scrib plays a role in the assembly of the EPB, it is
dispensable for envelope formation and barrier function.
As our data demonstrates that Scrib is not essential
for EPB formation and keratinocyte maturation, this sug-
gests the presence of a compensatory mechanism, as
previously proposed for delayed SC maturation following
glucocorticoid, estrogen or thyroid hormone reduction
and deletion of proliferator-activated receptor (PPAR)-α/δ
[53–57]. While the rescue of EPB acquisition in Scrib
KO embryos is likely to reflect the functional redun-
dancy within the polarity network [1, 58, 59] and/or
cell intrinsic/extrinsic signalling events mediated by
Scrib protein:protein interactions [1–4], future work is
necessary to determine how the epidermal development
regulation pathways interact. Of note, Scrib has been
shown to bind thyroid-stimulating hormone receptor
(TSHR) to mediate receptor recycling [60] and
hypothyroid mice that harbor a TSHR functional muta-
tion also display a transient delay in SC and EPB for-
mation [53].
We and others have previously demonstrated that
Scrib plays a potent tumor suppressive role in mam-
mary, prostate and lung epithelium in the presence of an
additional oncogenic event in vivo [7, 27, 29, 30]. In
agreement, our data is the first to establish that Scrib is
an effective epidermal tumor suppressor during initi-
ation and progression of DMBA/TPA-driven cutaneous
papillomas, whereas Scrib depletion alone is not suffi-
cient to instigate epidermal tumorigenesis. Mechanistic-
ally, we show Scrib loss caused p53-independent
apoptosis evasion and reduced the number of cells ex-
pressing the DNA damage/pre-apoptotic sensor γH2AX
following DMBA/TPA application, thus providing a pro-
neoplastic environment in the epidermis. Furthermore,
Scrib loss can contribute to papilloma progression by
stimulating keratinocyte proliferation. Intriguingly, Iden
and colleagues have also reported the polarity protein
Par3 is not required for epidermal homeostasis in adult
mice, but exerts cell-type dependent pro- and anti-
tumorigenic activity during DMBA/TPA-driven skin le-
sions by regulating cell growth and survival [61], further
emphasising the importance of the polarity network dur-
ing cutaneous carcinogenesis.
Scrib has previously been shown to influence the
ability of cells to undergo apoptosis and anoikis in
untransformed and transformed cells [27, 30, 33, 62, 63].
Indeed, SCRIB depletion in c-MYC-transformed hu-
man mammary epithelial cells has been shown to
inhibit the Rac-JNK-c-Jun-Bim apoptotic pathway to facili-
tate c-MYC-driven mammary tumorigenesis [27], and
siRNA knockdown of SCRIB in HeLa cells infected with
the ESEV PDZ-binding motif of the avian influenza A virus
NS1 protein reduces virus-induced apoptosis [62]. Our data
supports the notion that Scrib mediates apoptosis and in
addition, raises the possibility that Scrib is required for
the recognition of DNA damage and/or DNA repair given
the reduction in the number of γH2AX-positive cells in
Scribfl/fl DMBA/TPA treated epidermis. It is tempting
to speculate that Scrib deletion reduces DMBA-
induced DNA damage recognition, thus contributing to
the observed apoptosis evasion in Scribfl/fl DMBA/
TPA-induced skin lesions. Interestingly the polarity
protein Par3 has been shown to interact with two regu-
latory subunits of DNA-dependent protein kinase
(DNA-PK) to mediate the repair of DNA double-strand
breaks [64], illustrating that the polarity programme
directly intersects with the DNA damage repair path-
way. It will be important in future studies to fully eluci-
date the extent to which apoptosis and cell survival are
regulated by the polarity network.
Importantly, our findings provide rationale to assess
whether Scrib holds prognostic value for skin cancer
patients. Indeed, evidence in the literature indicates
that human papilloma viruses (HPV) may facilitate the
development of SCCs [65, 66] and HPV is reported to
target SCRIB for ubiquitin-mediated degradation [67].
Consequently, Scrib loss presents a potential mechan-
ism whereby HPV infection can contribute to the
development of cutaneous skin cancers.
In conclusion, we have demonstrated that Scrib
mediates EPB acquisition during development and is a
potent tumor suppressor during carcinogen-induced
skin tumorigenesis and progression that renders cells
permissive to DMBA/TPA-induced apoptosis. Apop-
tosis evasion is a characteristic feature of cancer cells
that facilitates tumor initiation and progression, as well
as the development of drug resistance [68]. Under-
standing how a cell gains the ability to resist apoptosis
is instrumental to the design of innovative therapies,
and our results now indicate that Scrib can regulate
this process in skin cancer.
Methods
Experimental animals
EIIaCre and K14Cre transgenic mice that express Cre re-
combinase under the control of the EIIa and K14 pro-
moter have been published previously [37, 69]. Scrib KO
and Scrib floxed mice were generated in-house [7]. All
mice were maintained on an FVB/N out bred background
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and backcrossed at least 9 times. Mice were genotyped
from DNA isolated from tail biopsies, as described previ-
ously [7]. All animal studies were carried out according to
the Peter MacCallum Cancer Centre Animal Experimental
Ethics Committee regulations.
Toluidine blue skin permeability assay
Embryos were harvested at E16.5, E17.5 or E18.5 (n = 4–
10 per genotype), dehydrated and then rehydrated in a
graded series of MeOH in PBS on ice within 5 mins.
Embryos were stained with toluidine blue dye (0.1% w/v
in PBS) for 10 min and washed in PBS before being im-
aged under a dissection microscope (Olympus) with an
Olympus DP11 camera. Images (1.6x magnifications) were
stitched together using Adobe Photoshop CS5 software.
Embryonic limb development and skeletal analysis
Staining of E17.5 mouse embryos with alcian blue and
alizarin red was performed as previously described [70].
Skeletons were photographed in 100 % glycerol, n = 3–6
per genotype. Lysotracker analysis of E13.5 mouse limb
buds was performed as previously described [71], n = 3
per genotype.
Tissue isolation and histology
Tissue was harvested and fixed for no longer than 24 h
in 10 % neutral buffered formaldehyde at 4 °C before
being embedded in paraffin and sectioned at 4 μm. Sec-
tions were stained with haematoxylin and eosin for
histological analysis by a certified pathologist.
Immunohistochemistry and immunofluorescence staining
Staining was carried out as described previously [7, 29,
72]. Primary antibodies include Cleaved Caspase-3 1:100
(9664, Cell Signalling Technology), PCNA 1:200 (610665,
BD Biosciences Pharmingen), Scrib 1:150 (SC1409, Santa
Cruz Biotechnology Inc.), Cytokeratin 10 1:100 (ab9026,
Abcam), Loricrin 1:1000 (PRB-145P, Covance), BrdU
1:150 (#347-580, BD Biosciences) ZO-1 1:50 (61–7300,
Thermo Scientific), γH2AX 1:300 (#NB100-2280, Novus
Biologicals), p-ERK1/2 (Thr 202/Tyr204) 1:150 (4376, Cell
Signaling Technology), F4/80 1:200 (MCA497G, AbD Ser-
otec), p53 1:200 (SC-6243, Santa Cruz), p21 1:100 (SC-
397, Santa Cruz), CK5 1:1000 (PRB-160P, Covance) and
CK6 1:500 (PRB-169P, Covance). Negative control slides
were run without primary antibody, and positive control
slides were incorporated. IHC/IF scoring was performed
either manually (untreated and short-term DMBA/TPA
treatment analysis) or using Molecular Devices Meta-
Morph 6.3 software (long-term DMBA/TPA treatment
analysis) from 6–10 images per mouse (×40 magnifica-
tion, BX-61 Olympus microscope). All experiments
were performed using embryonic flank epidermis, adult
dorsal skin or DMBA/TPA-driven skin lesions as
indicated.Mast cell stainingFFPE sections were rehy-
drated and incubated in 0.5% aqueous potassium per-
manganate for 2 minutes, rinsed in distilled water and
incubated in 2% aqueous potassium metabisulphite for
1 minute. After washing in distilled water, sections
were incubated for 5 min in acidified toluidine blue so-
lution (0.25 ml glacial acetic acid, 0.02g toluidine blue
in 99.75 ml distilled water), rinsed in distilled water
and dehydrated prior being coverslipped.
Ultrastructural analysis
Tissue was fixed in 2 % paraformaldehyde, 2.5 % glutar-
aldehyde in 0.08 M Sorensen’s phosphate buffer (PBS)
for 2 h and washed in PBS before being immersed in
2 % osmium tetroxide in PBS and dehydrated through a
graded series of alcohols, two acetone rinses and embed-
ding in Spurrs resin. Sections approximately 80 nm thick
were cut with a diamond knife (Diatome, Switzerland)
on an Ultracut-S ultramicrotome (Leica, Mannheim,
Germany) and contrasted with uranyl acetate and lead
citrate. Images were captured with a Megaview II cooled
CCD camera (Soft Imaging Solutions, Olympus) using a
JEOL 1011 transmission electron microscope (TEM).
Quantitation of epidermal layer thickness
Using Molecular Devices MetaMorph 6.3 software, epi-
dermal thickness (i.e. the distance between the basement
membrane and epidermal surface) was measured 3 inde-
pendent times on 10 H&E images (4 μm thick) for each
embryo. SC and SG thickness was measured 3 independ-
ent times on 5 toluidine blue stained ultramicrotome
sections (80 nm thick) for each embryo. Scored images
of flank epidermis were taken at 40x magnification (n = 3
per genotype/time point).
QRT-PCR analysis
RNA was isolated using TRizol (Invitrogen), TURBO
DNase treated (Ambion), and reverse transcribed with
Superscript III (Invitrogen). Amplification of cDNA was
performed by the StepOne-Plus Real-Time PCR System
(Applied Biosystems). Samples were normalized to
Gapdh, and Scrib mRNA fold change was calculated as
described previously [7]. Lgr5 mRNA expression was de-
tected as described previously [73].
DMBA/TPA administration
Chemical skin carcinogenesis was initiated at 8 weeks of
age on shaved dorsal skin by a single topical treatment
with 25 μg DMBA (Sigma Aldrich) in 50 μl acetone.
One week post-DMBA initiation, biweekly topical appli-
cation of 7.6 nmol TPA (Sigma Aldrich) in 150 μl acet-
one were performed for; (i) 20 week, with an additional
6 weeks without TPA (long-term study, n = 12–16 per
genotype) or (ii) 4 weeks (short-term, n = 4–7 per
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genotype). Mice were shaved, imaged and lesion volume
recorded on a weekly basis and animals harbouring
lesions >1 cm in diameter were sacrificed in accordance
with our ethical limit.
Statistical analysis
Statistical analysis was performed using GraphPad
Prism 6 software using either a two-tailed unpaired
t-test (95 % confidence interval) or a two-way
ANOVA (with Tukey correction) as indicated. H&E,
IHC staining and qRT-PCR quantitation was ana-
lysed statistically for at least 3 mice per genotype.
QRT-PCR reactions were performed in triplicate, and
a P value less than 0.05 was considered statistically
significant. Error bars represent standard deviation
(SD) or standard error of the mean (SEM) as
indicated.
Additional files
Additional file 1: Figure S1. Cell polarity is not deregulated in Scrib KO
embryonic epidermis. (A) IF to detect pan-Dlg (green) and DAPI (blue)
and (B) IF to detect E-cadherin (red) and DAPI (blue) in Scrib Wt, Het and
KO embryonic epidermis at E17.5 (n = 3, scale bar = 50 μm, dashed line
represents basement membrane). (PPTX 539 kb)
Additional file 2: Figure S2. Scrib is not essential for epidermal
homeostasis in adult mice. (A) qRT-PCR to detect Lgr5 confirmed Scrib+/+,
Scrib+/fland Scribfl/fl adult dorsal epidermis display a similar level of Lgr5
mRNA transcript expression (P ≥ 0.1013, unpaired t-test, error bars = SD,
n = 3). (B) IHC to detect cytokeratin 6 (K6) in Scrib+/+, Scrib+/fl and Scribfl/fl
adult dorsal epidermis (scale bar = 50 μm, n = 3). (C) IF to detect cytokeratin
5 (K5, green), cytokeratin 10 (K10, red) and DAPI (blue) in Scrib+/+, Scrib+/fl and
Scribfl/fl adult dorsal epidermis (scale bar = 50 μm, n = 3). Adult dorsal epider-
mis was harvested from mice 100 days old. (PPTX 755 kb)
Additional file 3: Figure S3. Analysis of Scrib-deficient DMBA/TPA-
driven epidermal lesions. (A) Kaplan Meier survival plot for DMBA/TPA
treated Scrib+/+, Scrib+/fl and Scribfl/fl mice. The average survival of Scribfl/fl
mice (23.5 weeks post-DMBA) was comparable to Scrib+/+ and Scrib+/fl
mice (24.5 and 24.9 weeks post-DMBA respectively). No statistical difference
in survival was observed between genotypes (χ2 = 0.029 – 2.15, df = 1, P≥
0.1426, Log-rank Mantel-Cox test, n = 12–16). (B) qRT-PCR for Scrib mRNA
confirmed a significant reduction in Scrib+/fl and Scribfl/fl volume-matched
(40 – 80 mm3) early benign papillomas compared to Scrib+/+ lesions
(*p < 0.0001, unpaired t-test, n = 3). (C) IF to detect Scrib (green) and
DAPI (blue) in Scrib+/+, Scrib+/fl and Scribfl/fl DMBA/TPA-induced size-
matched benign papillomas (n = 3, scale bar = 50 μm, insert 1–3 scale
bar = 10 μm). Representative p-ERK IHC images (D) and quantitation (E)
from Scrib+/+, Scrib+/fl and Scribfl/fl DMBA/TPA-induced size-matched
benign papillomas (scale bar = 50 μm, P ≥ 0.5919, unpaired t-test, error
bars = SD, n = 3). (F) IF to detect ZO-1 (green), E-cadherin (red) and DAPI
(blue) in Scrib+/+, Scrib+/fl and Scribfl/fl DMBA/TPA-induced size-matched
benign papillomas (n = 3, scale bar = 50 μm). (PPTX 1616 kb)
Additional file 4: Figure S4. Analysis of proliferation and immune
response to short-term DMBA and/or TPA treatment in Scrib-deficient
mice. (A) IHC to detect BrdU in Scrib+/+, Scrib+/fl and Scribfl/fl dorsal epidermis
that has undergone short-term treatment with either acetone, DMBA or
TPA. (B) IHC to detect F4/80 and identify macrophages and (C) toluidine
blue staining to detect mast cells in Scrib+/+, Scrib+/fl and Scribfl/fl dorsal
epidermis that has undergone short-term treatment with either acetone,
DMBA, TPA or DMBA/TPA. Scale bar = 50 μm, n = 3. (PPTX 4121 kb)
Additional file 5: Figure S5. Analysis of short-term DMBA and/or TPA
induced apoptosis in Scrib-deficient mice. IHC to detect (A) CC3 and (B)
γH2AX in Scrib+/+, Scrib+/fl and Scribfl/fl dorsal epidermis that has undergone
short-term treatment with either acetone, DMBA or TPA (scale bar = 50 μm,
n = 3). (C) Representative IHC images to detect p53 and p21 (scale bar =
50 μm, n = 3) and quantitation of p53 (D) and p21 (E) IHC (P ≥ 0.4776,
unpaired t-test, error bars = SD, n = 3) in Scrib+/+, Scrib+/fl and Scribfl/fl
dorsal epidermis that has undergone short-term treatment with DMBA/
TPA. (PPTX 2730 kb)
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